Skip to content
Open access

Hemicyanine-Based Wash-Free Near-Infrared Fluorescent Probe for Imaging Amyloid-β Aggregates in Alzheimer’s Disease

Oct 2026 · Molecules · Vol 31, pp. 3624 · 0 citations · 48 references
Medicine

TL;DR

By fine-tuning the amphiphilicity of a hemicyanine scaffold to place its log P within the appropriate range, P3 is identified as a wash-free NIRF probe for Aβ aggregates and provides a wash-free, high-affinity NIRF probe for Aβ imaging.

Abstract

As a key biomarker of Alzheimer’s disease (AD), amyloid-β (Aβ) is frequently employed for the diagnosis of AD. Near-infrared fluorescence (NIRF) imaging is a non-invasive, low-cost route for visualizing Aβ in vivo. However, most existing Aβ NIRF probes require tedious washing steps, show modest fluorescence turn-on (<50-fold), and stain normal tissue non-specifically. In this work, by fine-tuning the amphiphilicity of a hemicyanine scaffold to place its log P within the appropriate range, we identified P3 as a wash-free NIRF probe for Aβ aggregates. P3 bound Aβ aggregates with high affinity. In vivo, P3 distinguished AD mice from wild-type mice with a 4.8-fold signal ratio, together with adequate brain uptake (1.5 ± 0.1 ID/g at 20 min) and rapid clearance. Unlike Thioflavin T, which indiscriminately labels Aβ aggregates and normal neurons, P3 specifically labeled Aβ aggregates with negligible background, which enabled wash-free imaging with a signal-to-noise ratio of 80 ± 4. This work provides a wash-free, high-affinity NIRF probe for Aβ imaging.

Read PDF

Similar papers

Sep 2026

Indolizine-Based Small-Molecule Fluorescent Probes for Ex Vivo Imaging of Amyloid-β Plaques.

Indolizine is established as a promising scaffold for the development of complementary fluorescence imaging tools for AD-related ex vivo tissue studies and highlights the utility of ex vivo tissue-based screening for fluorescent-probe discovery.

I. Park, Kyeonghwan Kim, Sunhee Lee et al. · 0 citations
Dec 2026

Construction of a robust fluorescent probe for the rapid evaluation of natural products' inhibition of Alzheimer's disease.

Peroxynitrite (ONOO-) is a key oxidative stress biomarker for Alzheimer's disease (AD), and elevated levels of ONOO- in the brain directly reflect the extent of oxidative stress-induced damage in AD. To enable in situ real-time monitoring of ONOO-, this study designed and synthesized a ratiometric near-infrared fluores...

Xiao-Fang Xu, Xiu Xu, Li-Yi Zhou et al. · 0 citations
Oct 2026

Long-alkyl-chain-modified near-infrared fluorescent probe for in vivo visualization of viscosity and ONOO- in inflammation.

BACKGROUND Rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) are prevalent immune diseases that pose substantial global public health burdens. Early, accurate molecular imaging of inflammatory biomarkers in situ remains a major challenge. RESULTS Herein, we rationally designed a novel near-infrared (NIR)...

Chuan-Meng Liu, Li-Ying Wei, Yun-Fan Liu et al. · 0 citations
Open access Oct 2026

Novel NIR DDNP-type solvatochromic and fluorogenic probes for amyloid β detection.

Selective near-infrared fluorescent probes for amyloid β aggregates are of considerable interest as molecular imaging tools for the diagnosis and study of Alzheimer's disease. Herein, we describe the rational design and synthesis of DDNP-type donor-π-acceptor fluorophores incorporating a fixed N,N-dimethylamino donor g...

Matic Rogan, L. Blinc, Luka Rejc et al. · 0 citations
Open access Sep 2026

Design of bifunctional pyridinophane ligands as Mn2+ MRI agents for diagnostic imaging of Alzheimer's disease

The diazapyridinophane scaffold is established as a viable first-generation platform for blood–brain barrier (BBB)–permeable Mn2+ MRI contrast agents and both the bifunctional chelators and their Mn2+ complexes exhibit appreciable affinity for Aβ aggregates.

T. El Sayed, Akhil Patel, Ke-Rui Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.